Hypoxia has long been identified to co-exist with chronic inflammation in tumors [15, 16, 28, 29] and HIF-1α, a master regulator of tumor hypoxia, is known to be regulated in NFкB dependent manner and cooperatively maintain malignant phenotypes in cancer [16, 43, 44]. This evidence concerns the gene HIF1A and cancer.